Amneal Pharmaceuticals has introduced a bold new brand and visual identity that reflects the company’s evolution into a diversified global biopharmaceutical leader and reinforces its purpose of reimagining what’s possible to make medicine accessible for all.

Since its founding over 20 years ago, Amneal has been guided by a simple belief: essential medicines should be accessible to everyone. What began as a promise to deliver high-quality and affordable medicines, has grown into a diversified portfolio of affordable medicines spanning complex generics and injectables, biosimilars and specialty, with scale and capabilities that reach patients across the healthcare system.

Currently, Amneal delivers over 160 million prescriptions annually across a portfolio of more than 290 medicines, including many complex and hard-to-make products, helping patients manage chronic conditions, address unmet medical needs and access therapies that might otherwise be out of reach.

“As Amneal has grown and diversified, our brand needed to evolve with us. This new brand reflects who we are today and where we are headed. It signals our ambition, our capabilities, and our unwavering focus on expanding access to medicines that make a meaningful difference in people’s lives,” said Chirag Patel, Co-Founder and Co-Chief Executive Officer.

The new brand brings Amneal’s purpose to life through a modern visual identity grounded in trust, humanity and access. The company’s refreshed “Signature” logo is inspired by the act of prescribing, symbolising the trust placed in healthcare providers and the real-world impact each prescription has on patients. The evolved mark underscores Amneal’s role in helping bridge access to medicines across increasingly complex therapeutic areas and delivery systems.

“Our purpose has always been about access, perseverance and doing the hard things others don’t do,” said Chintu Patel. This brand evolution honours that legacy while boldly positioning Amneal for the future. It reflects the scale we have achieved, the complexity we take on, and our commitment to building a more sustainable healthcare system, Co-Founder and Co-Chief Executive Officer.

The new brand also provides a foundation for future initiatives that will further differentiate Amneal, including plans to introduce its Accessibility Index later this year, a platform intended to help fuel informed conversations around and demonstrate real impact on affordability, availability, innovation and knowledge.